Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2001 1
2003 2
2007 1
2009 1
2010 2
2011 1
2012 2
2013 1
2014 4
2015 2
2016 1
2017 3
2018 3
2019 3
2020 2
2021 5
2022 1
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Takada M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Ohno S, Ishiguro H, Kanbayashi C, Miyamoto T, Hagiwara Y, Toi M. Takada M, et al. Among authors: kanbayashi c. Breast Cancer Res Treat. 2023 Dec;202(3):485-496. doi: 10.1007/s10549-023-07099-4. Epub 2023 Sep 7. Breast Cancer Res Treat. 2023. PMID: 37676450 Free PMC article.
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi M, Ling Y, Toshikawa C, Hayashida T, Kitagawa Y, Futamura M, Kuwayama T, Nakamura S, Yamauchi H, Yamauchi T, Kaneko K, Kanbayashi C, Sato N, Tsuchida J, Moro K, Nakajima M, Shimada Y, Ichikawa H, Lyle S, Miyoshi Y, Takabe K, Okuda S, Wakai T. Nagahashi M, et al. Among authors: kanbayashi c. Breast Cancer. 2023 Jul;30(4):584-595. doi: 10.1007/s12282-023-01449-2. Epub 2023 Mar 17. Breast Cancer. 2023. PMID: 36930419
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Sasada S, Kondo N, Hashimoto H, Takahashi Y, Terata K, Kida K, Sagara Y, Ueno T, Anan K, Suto A, Kanbayashi C, Takahashi M, Nakamura R, Ishiba T, Tsuneizumi M, Nishimura S, Naito Y, Hara F, Shien T, Iwata H. Sasada S, et al. Among authors: kanbayashi c. Breast Cancer Res Treat. 2023 Dec;202(3):473-483. doi: 10.1007/s10549-023-07097-6. Epub 2023 Sep 9. Breast Cancer Res Treat. 2023. PMID: 37688665 Free PMC article.
Alopecia neoplastica: A manifestation of metastatic breast cancer.
Kitayama S, Katsuumi K, Takatsuka S, Kanbayashi C, Shimizu T, Takenouchi T. Kitayama S, et al. Among authors: kanbayashi c. Skin Health Dis. 2023 Oct 13;3(6):e302. doi: 10.1002/ski2.302. eCollection 2023 Dec. Skin Health Dis. 2023. PMID: 38047252 Free PMC article.
[Trastuzumab-associated cardiac dysfunction].
Okada Y, Kanbayashi C, Sato N. Okada Y, et al. Among authors: kanbayashi c. Gan To Kagaku Ryoho. 2010 Apr;37(4):665-9. Gan To Kagaku Ryoho. 2010. PMID: 20414023 Japanese.
Mentorship as Experienced by Women Surgeons in Japan.
Yorozuya K, Kawase K, Akashi-Tanaka S, Kanbayashi C, Nomura S, Tomizawa Y. Yorozuya K, et al. Among authors: kanbayashi c. World J Surg. 2016 Jan;40(1):38-44. doi: 10.1007/s00268-015-3245-8. World J Surg. 2016. PMID: 26404528
Probiotics reduce infectious complications after pancreaticoduodenectomy.
Nomura T, Tsuchiya Y, Nashimoto A, Yabusaki H, Takii Y, Nakagawa S, Sato N, Kanbayashi C, Tanaka O. Nomura T, et al. Among authors: kanbayashi c. Hepatogastroenterology. 2007 Apr-May;54(75):661-3. Hepatogastroenterology. 2007. PMID: 17591036 Clinical Trial.
Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.
Toyoda K, Yamagami H, Kitagawa K, Kitazono T, Nagao T, Minematsu K, Uchiyama S, Tanahashi N, Matsumoto M, Nagata I, Nishikawa M, Nanto S, Shirai T, Abe K, Ikeda Y, Ogawa A; PRASTRO Trial Investigators*. Toyoda K, et al. Stroke. 2021 Apr;52(4):1234-1243. doi: 10.1161/STROKEAHA.120.032824. Epub 2021 Feb 10. Stroke. 2021. PMID: 33563017 Free article. Clinical Trial.
40 results